Nasdaq:US$15.14 (-0.26) | HKEX:HK$23.80 (+0.04) | AIM:£2.24 (+0.04)
搜索
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2010-10-16

ISSX 2011: Preclinical assessment of the absorption, distribution, metabolism and excretion of HMPL-013 (fruquintinib), a novel potent and specific VEGFR inhibitor